Skip to main content

Advertisement

SpringerLink
Log in

CYP24A1 deficiency causing persistent hypercalciuria in a stone former

  • Lessons for the Clinical Nephrologist
  • Published:
Journal of Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Figueres L, Hourmant M, Lemoine S (2020) Understanding and managing hypercalciuria in adults with nephrolithiasis: keys for nephrologists. Nephrol Dial Transplant 35(4):573–575

    Article  Google Scholar 

  2. Ketha H, Kumar R, Singh RJ (2016) LC-MS/MS for identifying patients with CYP24A1 mutations. Clin Chem 62:236–242

    Article  CAS  Google Scholar 

  3. Figueres ML, Linglart A, Bienaime F, Allain-Launay E et al (2015) Kidney function and influence of sunlight exposure in patients with impaired 24-hydroxylation of vitamin D due to CYP24A1 mutations. Am J Kidney Dis 65:122–126

    Article  CAS  Google Scholar 

  4. Halbritter J, Baum M, Hynes AM, Rice SJ et al (2015) Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis. J Am Soc Nephrol 26:543–551

    Article  CAS  Google Scholar 

  5. Howles SA, Wiberg A, Goldsworthy M, Bayliss AL et al (2019) Genetic variants of calcium and vitamin D metabolism in kidney stone disease. Nat Commun 10:5175

    Article  Google Scholar 

  6. Oddsson A, Sulem P, Helgason H, Edvardsson VO et al (2015) Common and rare variants associated with kidney stones and biochemical traits. Nat Commun 6:7975

    Article  CAS  Google Scholar 

  7. Hill FJ, Sayer JA (2017) Clinical and biochemical features of patients with CYP24A1 mutations. In: A critical evaluation of vitamin D—basic overview, Gowder S (ed). IntechOpen.https://doi.org/10.5772/64503

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, 200 First Street Southwest, Rochester, MN, 55905, USA

    Janina Paula T. Sy-Go, Ladan Zand, Peter C. Harris & John C. Lieske

Authors
  1. Janina Paula T. Sy-Go
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ladan Zand
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter C. Harris
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John C. Lieske
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Janina Paula T. Sy-Go.

Ethics declarations

Conflict of interest

Drs. Sy-Go, Zand, and Harris have no conflict of interest. Dr. Lieske reports grants from Allena, Alnylam, Dicerna, OxThera, Synlogic, Orfan, and Novobiome, all of which are outside the submitted work.

Ethical statement

This article does not involve any study with human or animal subjects performed by any of the authors.

Informed consent

Informed consent was obtained from the patient.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sy-Go, J.P.T., Zand, L., Harris, P.C. et al. CYP24A1 deficiency causing persistent hypercalciuria in a stone former. J Nephrol 34, 949–951 (2021). https://doi.org/10.1007/s40620-020-00927-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40620-020-00927-6

Search

Navigation